Richmond Pharmacology is pleased to confirm our attendance at the FPM Annual Symposium 2025 in London, a leading event hosted by the Faculty of Pharmaceutical Medicine, dedicated to advancing professional excellence in pharmaceutical medicine and clinical research.

The symposium will bring together clinicians, researchers, and industry leaders to discuss the latest developments in drug development, clinical pharmacology, and regulatory science.

Representing Richmond Pharmacology:
• Dr Lisa Campbell, Director of Regulatory Strategy

 

Dr Campbell will take a deep dive into pharmaceutical medicine’s future role in advancing the health of women, highlighting how innovation in research, regulation, and clinical practice can address unmet needs, improve equity, and shape the next generation of therapeutic development.

If you are attending the FPM Annual Symposium and would like to learn how Richmond Pharmacology can support your clinical development programmes, we welcome you to connect with us during the event.

For meeting requests or collaboration enquiries:
📧info@richmondpharmacology.com

Learn more about the event: FPM Annual Symposium 2025 'Innovation in times of global uncertainty'

 

Latest news

Richmond Pharmacology Appoints Dr Daniel Chapple as Commercial Director

July 13, 2026
Richmond Pharmacology, the London-based contract research organisation and global leader in early phase clinical trials, announces the appointment of Dr Daniel Chapple PhD FCIM as Commercial Director.
Read more

Upcoming Event

ESC Congress 2026

28 - 31 August 2026
Richmond Pharmacology is pleased to attend the ESC Congress 2026 in Munich, Germany, on 28 - 31 August 2026.
View event